A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01482390
Recruitment Status : Completed
First Posted : November 30, 2011
Last Update Posted : April 24, 2017
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 31, 2014
  Actual Study Completion Date : January 31, 2014
  Certification/Extension First Submitted : August 9, 2016